文献速递免疫规划职业卫生卫生政策与健康促进

同源与异源COVID-19 mRNA疫苗接种方案在医护人员中诱导基础免疫对长期刺突特异性细胞免疫的免疫原性相似

Heterologous and homologous COVID-19 mRNA vaccination schemes for induction of basic immunity show similar immunogenicity regarding long-term spike-specific cellular immunity in healthcare workers.
PubMed 文献 · Vaccine · 2024-07-20

研究纳入356名已接种疫苗的医护人员,评估同源(三剂BNT162b2 mRNA)或异源(前两剂BNT162b2 mRNA后第三剂mRNA-1273)接种及突破感染对细胞免疫的影响。结果显示,有突破感染者的杂交免疫T细胞反应强;同源与异源接种者Spike特异性T细胞和B细胞百分比相似,提示两种mRNA疫苗免疫原性相似;吸烟者T细胞免疫反应显著降低(p<0.0001)。

要点

  • 有突破感染医护人员的杂交免疫对Spike-S1抗原T细胞反应强。
  • 同源与异源mRNA接种者Spike特异性T细胞和B细胞百分比相似。
  • 吸烟者T细胞免疫反应显著降低(p<0.0001)。

核心结论

  • 同源与异源COVID-19 mRNA疫苗接种方案在无突破感染的医护人员中诱导相似的Spike特异性B细胞和T细胞免疫原性;有突破感染的杂交免疫者T细胞反应尤其强;吸烟者T细胞免疫反应显著降低(p<0.0001)。

研究设计与样本

  • 在356名已接种疫苗且有或无突破感染的医护人员中,采用Interferon-gamma-ELISpot和流式细胞术评估抗SARS-CoV-2-Spike-IgG浓度与亲和力及针对SARS-CoV-2-Spike-S1和Nucleocapsid抗原的B细胞和T细胞反应性。

主要发现

  • 有突破感染导致杂交免疫的医护人员对Spike-S1抗原表现出强T细胞反应性。
  • Lasso回归模型显示吸烟者T细胞免疫反应显著降低(p<0.0001),年龄、性别、异源接种、体重指数、抗Nucleocapsid T细胞反应性、距上次COVID-19免疫天数及抗SARS-CoV-2-Spike-IgG的影响较小。
  • 亚组分析显示异源接种后抗SARS-CoV-2-Spike-IgG较高,但同源与异源接种之间细胞反应性及Spike反应性T细胞和B细胞百分比相似。
  • 抗SARS-CoV-2-Spike-IgG浓度和亲和力与活化T细胞显著相关,CD4+和CD8+反应相互相关。

临床怎么用

  • 作者认为,应将强长期细胞免疫反应作为医护人员加强针推荐的基础,并优先考虑吸烟者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Healthcare workers (HCWs) are recommended to receive at least three spike-antigen exposures to generate basic immunity and to mediate herd protection of vulnerable patients. So far, less attention has been put on the cellular immune response induced by homologous (three BTN162b2mRNA doses) or heterologous (mRNA-1273 as third dose building on two BTN162bmRNA doses) and the immunological impact of breakthrough infections (BTIs). Therefore, in 356 vaccinated HCWs with or without BTIs the Anti-SARS-CoV-2-Spike-IgG concentrations and avidities and B- and T-cell-reactivity against SARS-CoV-2-Spike-S1- and Nucleocapsid-antigens were assessed with Interferon-gamma-ELISpot and by flow-cytometry. HCWs who had hybrid immunity due to BTIs exhibited strong T-cell-reactivity against the Spike-S1-antigen. A lasso regression model revealed a significant reduction in T-cell immune responses among smokers (p < 0.0001), with less significant impact observed for age, sex, heterologous vaccination, body-mass-index, Anti-Nucleocapsid T-cell reactivity, days since last COVID-19-immunization, and Anti-SARS-CoV-2-Spike-IgG. Although subgroup analysis revealed higher Anti-SARS-CoV-2-Spike-IgG after heterologous vaccination, similar cellular reactivity and percentages of Spike-reactive T- and B-cells were found between homologous and heterologous vaccination. Anti-SARS-CoV-2-Spike-IgG concentrations and avidity significantly correlated with activated T-cells. CD4 + and CD8 + responses correlated with each other. A strong long-term cellular immune response should be considered as baseline for recommendations of booster doses in HCWs with prioritization of smokers. HCWs presented significant T-cellular reactivity towards Spike-S1-antigen with particularly strong responses in hybrid immunized HCWs who had BTIs. HCWs without BTI presented similar percentages of Spike-specific B- and T-cells between homologous or heterologous vaccination indicating similar immunogenicity for both mRNA vaccines, BNT162b2mRNA and mRNA-1273.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wagenhäuser I, Almanzar G, Förg FB, et al. Heterologous and homologous COVID-19 mRNA vaccination schemes for induction of basic immunity show similar immunogenicity regarding long-term spike-specific cellular immunity in healthcare workers. Vaccine. 2024. PMID: 39034219. doi:10.1016/j.vaccine.2024.07.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。